• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech

cafead

Administrator
Staff member
  • cafead   Aug 12, 2024 at 06:02: PM
via Senseonics is planning to launch its 365-day continuous glucose monitor (CGM) in 4Q24.

The Germantown, MD-based company announced the launch plans for the Eversense 365 CGM and maintained its full-year guidance of $ 22 million to $24 million during a recent earnings call.

article source
 

<